A Randomized, Double-Blind, Placebo Controlled, Multi-Center, Phase II Study of Adding AMG 479, a Fully Human Monoclonal Antibody Against Insulin-Like Growth Factor Type 1 Receptor (IGF-1R) to First Line Chemotherapy in Patients With Optimally Debulked (less than 1 cm) Epithelial Ovarian Cancer
Latest Information Update: 30 Jan 2023
At a glance
- Drugs Ganitumab (Primary) ; Carboplatin; Paclitaxel
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 28 Jan 2023 This trial has been completed in Germany (End Date: 7 Nov 2014) according to European Clinical Trials Database record.
- 16 Dec 2021 This trial has been completed in France as per European Clinical Trials Database.
- 09 Oct 2021 Results published in the Gynecologic Oncology